Total Payments
$766,761
2024 Payments
$99,573
Companies
25
Transactions
844
Medicare Patients
2,662
Medicare Billing
$408,508
Payment Breakdown by Category
Other$424,239 (55.3%)
Consulting$230,396 (30.0%)
Travel$67,922 (8.9%)
Food & Beverage$22,081 (2.9%)
Research$21,797 (2.8%)
Education$326.47 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $367,482 | 166 | 47.9% |
| Consulting Fee | $230,396 | 76 | 30.0% |
| Travel and Lodging | $67,922 | 146 | 8.9% |
| Honoraria | $55,600 | 30 | 7.3% |
| Food and Beverage | $22,081 | 411 | 2.9% |
| Unspecified | $21,797 | 5 | 2.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,100 | 1 | 0.1% |
| Education | $326.47 | 7 | 0.0% |
| Entertainment | $57.71 | 2 | 0.0% |
Payments by Type
General
$744,964
839 transactions
Research
$21,797
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $436,169 | 496 | $0 (2024) |
| Inspire Medical Systems, Inc. | $149,354 | 85 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $73,662 | 110 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $56,279 | 41 | $0 (2024) |
| Fisher & Paykel Healthcare Inc | $19,393 | 6 | $0 (2024) |
| EISAI INC. | $16,222 | 29 | $0 (2022) |
| Axsome Therapeutics, Inc. | $11,988 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,254 | 1 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $916.66 | 2 | $0 (2023) |
| ZOLL Respicardia, Inc. | $211.61 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99,573 | 131 | Inspire Medical Systems, Inc. ($48,035) |
| 2023 | $73,625 | 124 | Inspire Medical Systems, Inc. ($22,012) |
| 2022 | $96,593 | 76 | JAZZ PHARMACEUTICALS INC. ($50,890) |
| 2021 | $129,958 | 102 | JAZZ PHARMACEUTICALS INC. ($63,624) |
| 2020 | $86,388 | 89 | Jazz Pharmaceuticals Inc. ($40,845) |
| 2019 | $114,130 | 137 | JAZZ PHARMACEUTICALS INC. ($113,660) |
| 2018 | $67,238 | 80 | Jazz Pharmaceuticals Inc. ($66,929) |
| 2017 | $99,257 | 105 | Jazz Pharmaceuticals Inc. ($79,700) |
All Payment Transactions
844 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,254.00 | General |
| 12/19/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,563.00 | General |
| Category: Narcoplepsy | ||||||
| 12/19/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Sleep | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $25.11 | General |
| Category: Narcoplepsy | ||||||
| 12/03/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $37.28 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Noctrix Health, Inc. | NIDRA (Device) | Food and Beverage | Cash or cash equivalent | $32.78 | General |
| Category: Restless Leg Syndrome | ||||||
| 11/21/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/16/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $71.99 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $1,600.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/07/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Consulting Fee | Cash or cash equivalent | $4,905.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/30/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $1,600.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/24/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/24/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $1,600.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/17/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $1,600.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| The Evaluation of a nasal pillows mask | Fisher & Paykel Healthcare Limited | $17,067 | 2 |
| A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA | Jazz Pharmaceuticals Inc. | $2,453 | 1 |
| CPAP In Home Assessment USA | Fisher & Paykel Healthcare Limited | $2,276 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 951 | 1,230 | $300,918 | $111,128 |
| 2022 | 9 | 517 | 678 | $271,998 | $72,371 |
| 2021 | 9 | 599 | 821 | $370,628 | $102,943 |
| 2020 | 8 | 595 | 837 | $473,950 | $122,065 |
Total Patients
2,662
Total Services
3,566
Medicare Billing
$408,508
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 385 | $63,525 | $35,268 | 55.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 450 | 543 | $73,305 | $34,509 | 47.1% |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 2023 | 37 | 81 | $52,650 | $10,330 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $18,675 | $10,172 | 54.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 16 | 18 | $43,020 | $7,880 | 18.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 18 | 18 | $38,520 | $7,820 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $4,725 | $2,213 | 46.8% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 34 | 36 | $2,520 | $1,514 | 60.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 39 | $3,978 | $1,423 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 191 | $31,515 | $16,706 | 53.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 29 | 30 | $71,700 | $13,703 | 19.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 29 | 29 | $62,060 | $12,034 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 182 | $24,563 | $10,588 | 43.1% |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 2022 | 42 | 77 | $50,050 | $10,437 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $9,000 | $3,401 | 37.8% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2022 | 70 | 73 | $5,110 | $3,224 | 63.1% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 12 | 24 | $15,600 | $1,756 | 11.3% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2022 | 14 | 32 | $2,400 | $522.38 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 252 | 355 | $56,235 | $32,343 | 57.5% |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 2021 | 120 | 188 | $122,200 | $26,300 | 21.5% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 31 | 32 | $76,480 | $15,341 | 20.1% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 27 | 27 | $57,780 | $11,425 | 19.8% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2021 | 25 | 57 | $37,050 | $6,940 | 18.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $8,325 | $4,394 | 52.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 61 | $7,953 | $3,847 | 48.4% |
About Dr. Asim Roy, M.D
Dr. Asim Roy, M.D is a Sleep Medicine healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639159767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Asim Roy, M.D has received a total of $766,761 in payments from pharmaceutical and medical device companies, with $99,573 received in 2024. These payments were reported across 844 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($367,482).
As a Medicare-enrolled provider, Roy has provided services to 2,662 Medicare beneficiaries, totaling 3,566 services with total Medicare billing of $408,508. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Location Dublin, OH
- Active Since 01/17/2006
- Last Updated 06/19/2013
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1639159767
Products in Payments
- Xyrem (Drug) $144,177
- XYWAV (Drug) $131,284
- SUNOSI (Drug) $83,655
- Inspire Upper Airway Stimulation System (Device) $79,307
- INSPIRE (Device) $70,047
- XYREM (Drug) $69,779
- Wakix (Drug) $62,118
- LUMRYZ (Drug) $56,279
- Dayvigo (Drug) $16,187
- Sunosi (Drug) $11,988
- WAKIX (Drug) $11,544
- SleepStyle (Device) $2,276
- remede System (Device) $211.61
- Horizant (Drug) $209.20
- HORIZANT (Drug) $141.30
- NIDRA (Device) $132.78
- WatchPAT (Device) $117.87
- IGT_D Peripheral (Device) $89.71
- AirSense (Device) $57.71
- FISHER & PAYKEL HEALTHCARE (Device) $49.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.